Fabienne Chatreaux
Aventis Pharma
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Fabienne Chatreaux.
Tetrahedron Letters | 2000
Laurent Schio; Fabienne Chatreaux; Michel Klich
Abstract The palladium-catalysed coupling reaction between tosylate derivatives and organostannanes has been investigated as a methodology for carbon–carbon bond formation. Aryl substituents have been successfully incorporated even in highly functionalised coumarin structures to afford new analogues of the antibiotic novobiocin.
Journal of Medicinal Chemistry | 2012
Victor Certal; Frank Halley; Angela Virone-Oddos; Cécile Delorme; Andreas Karlsson; Alexey Rak; Fabienne Thompson; Bruno Filoche-Romme; Youssef El-Ahmad; Jean Christophe Carry; Pierre Yves Abecassis; Pascale Lejeune; Loic Vincent; Hélène Bonnevaux; Jean Paul Nicolas; Thomas Bertrand; Jean Pierre Marquette; Nadine Michot; Tsiala Benard; Peter Below; Isabelle Vade; Fabienne Chatreaux; Gilles Lebourg; Fabienne Pilorge; Odile Angouillant-Boniface; Audrey Louboutin; Christoph Lengauer; Laurent Schio
Most of the phosphoinositide-3 kinase (PI3K) kinase inhibitors currently in clinical trials for cancer treatment exhibit pan PI3K isoform profiles. Single PI3K isoforms differentially control tumorigenesis, and PI3Kβ has emerged as the isoform involved in the tumorigenicity of PTEN-deficient tumors. Herein we describe the discovery and optimization of a new series of benzimidazole- and benzoxazole-pyrimidones as small molecular mass PI3Kβ-selective inhibitors. Starting with compound 5 obtained from a one-pot reaction via a novel intermediate 1, medicinal chemistry optimization led to the discovery of compound 8, which showed a significant activity and selectivity for PI3Kβ and adequate in vitro pharmacokinetic properties. The X-ray costructure of compound 8 in PI3Kδ showed key interactions and structural features supporting the observed PI3Kβ isoform selectivity. Compound 8 achieved sustained target modulation and tumor growth delay at well tolerated doses when administered orally to SCID mice implanted with PTEN-deficient human tumor xenografts.
Bioorganic & Medicinal Chemistry Letters | 2001
Laurent Schio; Fabienne Chatreaux; Véronique Loyau; Michel Murer; Anne Ferreira; Pascale Mauvais; Alain Bonnefoy; Michel Klich
A novel series of novobiocin analogues has been synthesised by removing the lipophilic aryl chain in novobiocin and introducing an amino substituent. The structural modifications have been dictated by the control of lipophilicity and the dissociation constant of the resulting compounds. Antibacterial activity of the new coumarin derivatives could be correlated with the amount of uncharged form in physiological conditions.
Bioorganic & Medicinal Chemistry Letters | 2000
Branislav Musicki; Anne-Marie Periers; Patrick Laurin; Didier Ferroud; Yannick Benedetti; Sylvette Lachaud; Fabienne Chatreaux; Jean-Luc Haesslein; Alain Iltis; Christine Pierre; Jean Khider; Nicole Tessot; Marlene Airault; Jacques Demassey; Claudine Dupuis-Hamelin; Patrice Lassaigne; Alain Bonnefoy; Pascale Vicat; Michel Klich
Archive | 2001
Didier Babin; Yannick Benedetti; Fabienne Chatreaux; John Weston
Archive | 2013
Jean-Christophe Carry; Fabienne Chatreaux; Stephanie Deprets; Olivier Duclos; Vincent Leroy; Sergio Mallart; Dominique Melon-Manguer; Maria Mendez-Perez; Fabrice Vergne
Archive | 2003
Didier Babin; Yannick Benedetti; Fabienne Chatreaux; John Weston
Archive | 2013
Jean-Christophe Carry; Fabienne Chatreaux; Stephanie Deprets; Olivier Duclos; Vincent Leroy; Sergio Mallart; Dominique Melon-Manguer; Maria Mendez-Perez; Fabrice Vergne
Archive | 2017
Jean-Christophe Carry; Fabienne Chatreaux; Stephanie Deprets; Olivier Duclos; Vincent Leroy; Sergio Mallart; Maria Mendez-Perez; Fabrice Vergne
Archive | 2012
Jean-Christophe Carry; Fabienne Chatreaux; Stephanie Deprets; Olivier Duclos; Vincent Leroy; Sergio Mallart; Dominique Melon-Manguer; Maria Mendez-Perez; Fabrice Vergne